Term
|
Definition
Broad spectrum
1ST – Rickettsia, Chlamydia
Good for intracellular bacteria because good penetration into host cells |
|
|
Term
|
Definition
-drug resistant Gram neg & MRSA; not good for UTI or blood (newest derivative, a glyclglycine) |
|
|
Term
|
Definition
Spectinomycin: MOA similar to aminoglycosides (aminocyclitol); Binds to 30S but is bacteriostatic. |
|
|
Term
|
Definition
Binds reversibly to 50S
Prevents peptide bond formation
BROAD SPECTRUM
Toxic effects – Aplastic anemia |
|
|
Term
Lincomycin and the derivative Clindamycin |
|
Definition
- Mechanism of action: Interference with peptide bond formation
- Effective against anaerobes: e.g. Bacteriodesfragilis
- Problem: May induce overgrowth of Clostridium difficile
|
|
|
Term
|
Definition
- reversible binding to 23S rRNA in 50S ribosomal subunit
- Erythromycin: Primarily effective against Gram + bacteria
- New derivatives: Azithromycin and Clarithromycin
- Erythromycin is the drug of choice for Mycoplasma pneumoniae infections and Legionairre’s Disease
|
|
|
Term
Oxazolidinones
Linezolid - ZYVOX
|
|
Definition
A synthetic antimicrobial agent that is the first in a new class of agents – designed from scratch. First new class in 40 years
Useful for Gram positive infections: First new drug for Staphylococcus infections in years. Tx: MRSA & VRE
Thought to attack an unexploited site: The proper assembly of the fmet-tRNA with mRNA and the 30S subunit. May also act by binding 50S and preventing 70S formation.
TOTALLY NEW TARGET
Neither linezolid or its chemical relatives have been used for animal infections or as growth promoters.
YET: resistance already reported (LRE/LRVRE)! |
|
|
Term
Rifamycins (Rifampin=Rifampicin; cidal) |
|
Definition
- Inhibit RNA synthesis by interacting with DNA-DEPENDENT, RNA POLYMERASE, preventing transcription; use with other drugs; used for TB, leprosy; prophylaxis of patient contacts of bacterial meningitis
|
|
|
Term
|
Definition
Fungistatic agent that affects fungal microtubles, inhibiting DNA replication and mitosis.
Ineffective if applied locally. Must be given orally – Collects in keratin. At the levels used, does not affect mammalian cells. |
|
|
Term
Quinolones/Fluoroquinolones |
|
Definition
|
|
Term
|
Definition
Anaerobes and Parasites: Must be reduced in the cytoplasm
by a nitroreductase to become active (Use: Anaerobes, H. pylori, protozoa)
|
|
|
Term
Intermediary Metabolism: Anti-folates |
|
Definition
Sulfonamides ------------> Synthetase
Trimethoprim ----------> Dihydrofolate Reductase
|
|
|
Term
|
Definition
1.Modification of the target so that it is insensitive to an inhibitor but still functions.
2.Duplication or replacement of the target enzyme
3.Prevent access to the target (efflux pump)
4.Depression of a metabolic activity that normally converts an inert agent into an active agent
5.**Synthesis of enzymes that inactivate an antimicrobial agent or modify the agent to alter entry or binding to a target |
|
|